Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,638.00p
   
  • Change Today:
    -6.00p
  • 52 Week High: 2,354.00
  • 52 Week Low: 1,630.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 13
  • Market Cap: £1,081.65m
  • RiskGrade: 128
  • Beta: 1.51

Key dates

Dividend  
Latest XD Date (Final) 07-Nov-2024
Latest Pay Date (Final) 06-Dec-2024
   
Meetings  
AGM 20-Nov-2024
EGM n/a
GMs n/a
   
Announcements  
Trading announcement 20-Nov-2024
IMSs 15-May-2014
Drilling Report n/a
   
Results  
Final results 05-Sep-2024
Interim results 27-Feb-2025
Q1 Results n/a
Q2 Results n/a
Q3 Results n/a
Q4 Results n/a
Annual Report 14-Oct-2024
   
Year End 30-Jun-2025

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 1,638.00p
Change Today -6.00p
% Change -0.37 %
52 Week High 2,354.00
52 Week Low 1,630.00
Volume 13
Shares Issued 66.03m
Market Cap £1,081.65m
Beta 1.51
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average
Price Trend Not Available
Income
77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 07-Nov-24 29-Feb-24
Paid 06-Dec-24 28-Mar-24
Amount 21.70p 10.30p

Trades for 22-Nov-2024

Time Volume / Share Price
08:05 2 @ 1,638.00p
08:00 11 @ 1,638.00p
08:00 1 @ 1,638.00p
08:00 1 @ 1,638.00p
08:00 1 @ 1,638.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page